PSA Response After Short-Term Hormonal Therapy Plus External Beam Radiotherapy and Outcome in Patients Treated on RTOG 9413

PURPOSE: Assess the impact of PSA-complete response (PSA-CR), measured at the end of external beam radiotherapy (EBRT) and short-term hormonal therapy (STHT), on treatment outcomes. DESIGN: The Phase III RTOG-9413 trial had as part of its original protocol the assessment of PSA-CR, i.e. PSA≤0.3ng/ml...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Cury, Fabio L., Hunt, Daniel, Roach, Mack, Shipley, William, Gore, Elizabeht, Hsu, I-Chow, Krisch, Robert E., Seider, Michael J., Sandler, Howard, Lawton, Colleen
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3663874/
https://ncbi.nlm.nih.gov/pubmed/23504930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28019
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky